Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Stichting Radboud Universitair Medisch Centrum |
| Country | Netherlands |
| Start Date | Feb 01, 2021 |
| End Date | Jan 31, 2027 |
| Duration | 2,190 days |
| Number of Grantees | 52 |
| Roles | Participant; Coordinator; Third Party |
| Data Source | European Commission |
| Grant ID | 945358 |
BIGPICTURE, a pathology-led consortium, has the vision to become the catalyst in digital transformation in Pathology.
Our mission is to create the first European GDPR compliant platform, in which both quality-controlled Whole Slide Imaging (WSI) data and advanced Artificial intelligence (AI) algorithms will exist.
The BIGPICTURE platform will be built on existing assets of ELIXIR EU data infrastructure, including the federated European Genome-phenome Archive (EGA) technology for managing the exchange of confidential information between contributors and users.
The consortium will use Cytomine, an established open-source, cross-platform framework to develop unique tools for access to WSI, including annotations and visualisation of algorithm results, while we will develop new and generic models to facilitate AI development and mining of WSI data.
By engaging and building consensus with all the relevant stakeholders, we will contribute to the development of a regulatory framework for digital slides and AI-based methods.
Finally, BIGPICTURE envisions sustainability of its platform through a community- based model which relies on reciprocity, value creation and inclusiveness.To achieve our vision, we have brought together Europe’s leaders in the field of computational pathology who have access to national and European high-performance computing infrastructures as well as Europe’s fully digitalised pathology departments.
Additionally, the consortium has currently access to approximately 4.5 million clinical WSI covering a wider range of indications through 17 partners and 23 third parties from the largest European and international pathology and trial groups.
Our consortium is further strengthened by the presence of the European Society of Pathology, Digital Pathology Association, FDA and 9 SMEs as partners, while we are further supported by professional societies, and patient advocates.
Medizinische Universitaet Wien; Linkopings Universitet; Region Ostergotland; Ttopstart Bv; Philipps Universitaet Marburg; Universite de Liege; Pfizer Limited; Digital Pathology Association Inc; Timelex; Hus-Yhtyma; Phit Bv; Medizinische Universitat Graz; Ucb Biopharma; Stichting Lygature; Biobanks and Biomolecular Resources Research Infrastructure Consortium (Bbmri-Eric); Stichting Radboud Universiteit; Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung Ev; Technische Universitaet Muenchen; Cytomine; Novartis Pharma Ag; The Leeds Teaching Hospitals National Health Service Trust; Gbg Forschungs Gmbh; Sectra Ab; F. Hoffmann-la Roche Ag; Uppsala Universitet; Din Deutsches Institut Fuer Normung Ev; Stichting Radboud Universitair Medisch Centrum; Owkin France; Umea Universitet; Cytomine Corporation Sa; Universitair Medisch Centrum Utrecht; Stichting Het Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis; European Society of Pathology; Institut Pasteur; Boehringer Ingelheim Internationalgmbh; Semmelweis Egyetem; University of Warwick; Universita' Degli Studi Di Milano-Bicocca; Bayer Aktiengesellschaft; Sanofi-Aventis Recherche & Developpement; Haute Ecole Specialisee de Suisse Occidentale; Novo Nordisk A/S; Institut de Recherches Internationales Servier; Technische Universiteit Eindhoven; Deciphex Limited; Katholieke Universiteit Leuven; Turun Yliopisto; The European Institute for Innovation Through Health Data; Janssen Pharmaceutica Nv; Csc-Tieteen Tietotekniikan Keskus Oy; Azienda Ospedaliera Per L Emergenza Cannizzaro; Diagnexia Uk Limited
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant